Christian Rommel
Net worth: - $ as of 31/12/2025
Profile
Christian Rommel currently works at AskBio Inc., as Director, Vividion Therapeutics, Inc., as Director, CRISPR Therapeutics AG, as Independent Director from 2024, and Bayer AG, as EVP, Head-Research & Development.
Dr. Rommel also formerly worked at Regeneron Pharmaceuticals, Inc., as Senior Scientist, Intellikine LLC, as Chief Scientific Officer from 2007 to 2012, Merck Serono Ltd., as Head-Target Research, Amgen, Inc., as VP-External Research & Development, and F.
Hoffmann-La Roche Ltd., as SVP, Head-Oncology Research & Early Development from 2018 to 2021.
Dr. Rommel received his doctorate degree from Max-Planck-Institute for Molecular Genetics and undergraduate degree from the University of Greifswald.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 05/06/2025 | 0 ( -.--% ) | - $ | 31/12/2025 |
Christian Rommel active positions
| Companies | Position | Start |
|---|---|---|
| BAYER AG | Chief Tech/Sci/R&D Officer | 01/02/2021 |
| CRISPR THERAPEUTICS AG | Director/Board Member | 13/03/2024 |
Asklepios BioPharmaceutical, Inc.
Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Engages in the development and delivery of novel protein and cellular based therapies | Director/Board Member | - |
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Director/Board Member | - |
Former positions of Christian Rommel
| Companies | Position | End |
|---|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/02/2021 |
Intellikine LLC
Intellikine LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs for the treatment of cancer | Chief Tech/Sci/R&D Officer | 01/12/2012 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | - |
Merck Serono Ltd.
Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services and manufactures medicinal drugs | Corporate Officer/Principal | - |
| REGENERON PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Christian Rommel
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Amgen, Inc.
Amgen, Inc. Discovers, develops, manufactures and delivers human therapeutics | |
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. Discovers, develops, manufactures and commercializes medicines for diseases | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bayer AG
Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Asklepios BioPharmaceutical, Inc.
Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Engages in the development and delivery of novel protein and cellular based therapies | Health Technology |
Max-Planck-Institute for Molecular Genetics
Max-Planck-Institute for Molecular Genetics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellikine LLC
Intellikine LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs for the treatment of cancer | Health Technology |
University of Greifswald
University of Greifswald Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Serono Ltd.
Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services and manufactures medicinal drugs | Commercial Services |
CRISPR Therapeutics AG
CRISPR Therapeutics AG Develops gene-based medicines | |
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders |
- Stock Market
- Insiders
- Christian Rommel
















